Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to -$0.16.

  • Ascendis Pharma A's Times Interest Earned fell 237690.0% to -$0.16 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2, marking a year-over-year increase of 10991.22%. This contributed to the annual value of $0.66 for FY2025, which is 12365.77% up from last year.
  • Ascendis Pharma A's Times Interest Earned amounted to -$0.16 in Q4 2025, which was down 237690.0% from -$0.16 recorded in Q3 2025.
  • Ascendis Pharma A's 5-year Times Interest Earned high stood at $478.53 for Q4 2022, and its period low was -$143.44 during Q1 2021.
  • For the 5-year period, Ascendis Pharma A's Times Interest Earned averaged around $20.85, with its median value being -$2.92 (2022).
  • Per our database at Business Quant, Ascendis Pharma A's Times Interest Earned crashed by 570451.13% in 2021 and then surged by 16962.64% in 2024.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Times Interest Earned stood at $287.93 in 2021, then surged by 66.2% to $478.53 in 2022, then crashed by 100.12% to -$0.57 in 2023, then skyrocketed by 98.87% to -$0.01 in 2024, then plummeted by 2376.9% to -$0.16 in 2025.
  • Its Times Interest Earned stands at -$0.16 for Q4 2025, versus -$0.16 for Q3 2025 and -$1.6 for Q2 2025.